Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangpo Liujun Prescription for Cancer-Related Fatigue in Advanced Colorectal Cancer
NCT06394128Phase 2Recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer-related fatigue (CRF) comparing Cangpo Liujun Prescription with Placebo (2 arms). Primary endpoint: Revised Piper Fatigue Scale at 3 months. Started Apr 2024; status: recruiting.
02
Drugs
Cangpo Liujun Prescription
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT06394128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06394128.